Clinical Trial Update: SGLT2i As Anti Arrhythmic Therapy to Prevent Sudden Cardiac Deaths.

View source ↗

Summary

A completed clinical trial (NCT03366181) evaluated whether SGLT2 inhibitors can serve as antiarrhythmic therapy to prevent sudden cardiac death in heart failure…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Heart Failure, ICD | Status: COMPLETED